Liletta
Drug Womens Health
NDC 0023-5858-01
General payments
$1,016,749
Research payments
$0
Through program year 2025, $1,016,749 in general payments and $0 in research payments were reported against Liletta (Womens Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $96,791 | 4,889 |
| 2024 | General | $112,695 | 5,329 |
| 2023 | General | $258,519 | 13,849 |
| 2022 | General | $285,854 | 16,546 |
| 2021 | General | $161,777 | 9,363 |
| 2020 | General | $73,993 | 1,392 |
| 2019 | General | $27,121 | 1,774 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 42 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
53,142 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.